Towards stem cell replacement therapies for Parkinson's disease
1Laboratory of Molecular Neurobiology, MBB, Center for Developmental Biology and Regenerative Medicine, Scheelevagen 1, 17177 Stockholm, Sweden. Ernest.Arenas@ki.se
Biochemical and Biophysical Research Communications
|May 25, 2010
Summary
Regenerative cell replacement therapies (CRT) are needed for Parkinson's disease (PD) as current treatments only manage symptoms. Stem cells show promise for PD CRT, but challenges remain for clinical application.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Therapy
Background:
- Parkinson's disease (PD) involves dopamine neuron loss, necessitating treatments beyond symptom management.
- Current therapies offer symptomatic relief but do not alter disease progression.
- Regenerative and cell replacement therapies (CRT) are crucial for addressing PD's underlying pathology.
Purpose of the Study:
- To review the current status and future potential of cell replacement therapies for Parkinson's disease.
- To discuss lessons learned from fetal tissue transplantation trials.
- To explore the role of stem cells in developing advanced PD therapies.
Main Methods:
- Review of clinical trials involving fetal tissue grafts for PD.
- Analysis of recent advancements in human stem cell-derived dopamine neuron development.
- Identification of challenges and future directions for stem cell-based PD CRT.
Main Results:
- Fetal tissue transplantation demonstrated proof of principle for CRT in PD but highlighted variability.
- Some patients showed significant improvement, while others experienced adverse effects like dyskinesias.
- Human stem cell-derived dopamine neurons are progressing as a potential source for PD CRT.
Conclusions:
- Cell replacement therapy holds promise for Parkinson's disease, but requires optimization.
- Stem cells offer a scalable and potentially safer alternative to fetal grafts.
- Further research is needed to overcome technical and biological hurdles for effective stem cell-based PD treatment.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.